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Abstract
To evaluate the index cases leading to the transmission of healthcare workers 
(HCWs) in Rize/Turkey Recep Tayyip Erdogan University Faculty of Medicine 
Education and Research Hospital with COVID-19 infection and the clinical features 
of infected HCWs. The first two COVID-19 test positive patients treated at Rize/
Turkey between 10.03.2020 and 12.04.2020 and HCWs those who examined these 
two patients whose COVID-19 PCR test results were positive were included in 
this study. In Rize/Turkey, the first and second cases of positive COVID-19 which 
was recorded on 13.03.2020 on 25.03.2020, 27 HCWs (female, 63%, n = 17 and 
male, 37%, n = 10 and the mean age was 33.2 ± 6.9 years) who contacted during 
the treatment of these cases and became COVID-19 positive were examined. The 
median of symptom duration (days) of the HCWs was 5 days (range: 0–17 days). 
Fever, 55.6% (n = 15); malaise, 44.4% (n = 12); cough, 40.7% (n = 11); sore 
throat, 33.3% (n = 9); myalgia, 33.3% (n = 9); dyspnea, 14.8% (n = 4); diarrhea, 
22.2% (n = 6); vomiting, 14.8% (n = 4); anosmia, 18.5% (n = 5); ageusia, 22.2% 
(n = 6) and headache, 37% (n = 10) of the cases. The rates of headache in female 
HCWs infected with COVID-19 were found to be significantly higher compared to 
men (52.9%). None of them had severe clinical situation requiring intensive care 
follow-up or acute respiratory distress syndrome (ARDS). Laboratory measure-
ments of HCWs were carried out at the first when they had symptoms and when 
they recovered, and results were compared accordingly. The thorax computerized 
tomography (CT) findings of HCWs were normal in 74.1% (n = 20) of total. HCWs 
were initially affected by the COVID-19 pandemic. Early measures provided by the 
Health authorities, access to diagnosis and treatment, and the young age average in 
HCWs prevented severe outcomes such as severe clinical course and mortality at the 
beginning of the outbreak.
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1. Introduction
COVID 19 continues to threaten health of the humankind [1, 2]. COVID-19 
is transmitted by close contact and droplets among people. However, airborne 
contamination may be possible under certain conditions and environments in 
which procedures or supportive treatments that produce aerosols are performed [3]. 
Those who are most at risk of getting this disease are those who have contact with 
the patient or those who provides care for them. Therefore, the protection of HCWs 
is considered as one of the top priorities [4–6].
In all countries with COVID-19 pandemic, the caught unaware staff was effec-
tive in the transmission, since the transmission dynamics of the COVID-19 virus 
was not fully known at the onset of the outbreak [7, 8]. With the reporting of the 
first cases, the protective equipment has been widespread used. The initial case 
diagnosis in our country were made with guides in the form of a history of interna-
tional contact and clinical definitions [8, 9]. Recently, as of September 2020, 601 
HCWs were positive for the COVID-19 test during the onset of the outbreak, and 
then it was reported as 7,428 health workers had been infected, which is around 6.5 
percent of the total number of cases [10].
The cases reported by our HCWs in the first week concurrently with the general 
course of the country, there was no history of traveling abroad and there had not 
been aware of suspected contacts. The fact that there were 27 HCWs in the first 
month and the first two index cases and 4 HCWs in the second month supported 
this outcome. During the epidemy, HCWs are under tremendous stress. Working 
with personal protective equipment (PPE) and performing specific procedures 
are cumbersome and were not convenient [11, 12]. Despite all these difficulties it 
was necessity to use highly protective respirators such as N95 or P2/FFP2/FFP3 for 
HCWs. Employees’ occupational health and safety should be given high priority and 
a uniform policy should be applied to use personal protective equipment to prevent 
infection [7].
We aimed to identify the clinical features of 27 HCWs who were in contact with 
the first two index cases infected with COVID-19 and compare them with previous 
studies.
2. Material and methods
After the first index cases were diagnosed, filiation and evaluation of concur-
rent symptomatic applicants were performed at the Infectious Diseases clinic. 
Retrospectively, clinical findings were classified as severe (1–14 days), moder-
ate (1–7 days), and mild (no hospitalization days), considering the duration of 
symptoms, length of hospital stay, and treatment practices. Patients with possible 
SARS-CoV-2 infection were examined via real-time RT-PCR and next-generation 
sequencing laboratory techniques. This study was approved by the Ministry of 
Health of Turkey, Scientific Research Ethics Committee No: Ayse Erturk-2020-05-
11T12_27_08 and local ethics committee RTEU Faculty of Medicine Rize/Turkey – 
No: 2020/82.
2.1 Statistical analysis
SPSS 17.0 (Chicago Inc., 2008) program was used in the analysis. Categorical 
variables were expressed in terms of frequency (n) and percent (%) and in 
arithmetic mean, standard deviation, median, minimum and maximum values. 
While the Student t-test was used for comparison of continuous distributors with 
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normal distribution, those without normal distribution were analyzed with the 
Mann–Whitney U test. Pearson-χ2 and Fisher’s exact tests were used for categori-
cal variables. Paired-t test and Wilcoxon signed rank tests were used to compare 
the first and second levels of laboratory measurement parameters. P < 0.05 was 
accepted as the level of significance.
3. Results
3.1 Features of index cases (patients)
Characteristics of a 75-year-old female patient who was reported as the first 
COVID-19 test positive patient in Rize on 13.03.2020, and a 69-year-old male 
patient who was positive on the tracheal aspirate COVID-19 test on 25.03.2020 were 
summarized as follows:
3.1.1 The Index patient 1
75 years-old, women. Place of birth and living: Rize province. The first-degree 
relative lives in Istanbul province. With the symptoms of fever, cough, shortness of 
breath, vomiting, chest pain, F.T was admitted to emergency service of Rize State 
Hospital on 10.03.2020 and she was hospitalized with diagnoses of primary hyper-
tension (HT), congestive heart failure (CHF), acute sub-endocardial myocardial 
infarction (MI), non-ST elevated acute myocardial infarction (AMI), and acute renal 
failure (ARF). On 13.03.20, she was transferred to the RTEU Training and Research 
Hospital Cardiology service. On 13.03.2020, the patient’s nasopharyngeal COVID-19 
sampling was performed. The patient was started on hydroxychloroquine 2x400 
mg loading and 2x200 mg/day maintenance doses (po), azithromycin 1x500 mg/
day (po), oseltamivir 2x30 mg/day (po), and piperacillin-tazobactam 4x3.375 g (1.5 
flacon) iv treatment. On the date of 22.03.2020, she was transferred 1st stage coro-
nary intensive care unit and intubated due to the deterioration in general condition, 
unconsciousness, hypotension, bradycardia, cyanosis, and decreased urine output.
Radiologically, there was no apparent opacity on the The posteroanterior (PA) 
chest X-ray dated 16.03.2020 (Figure 1a). Newly developed opacities in the right 
lung were noticeable on the control radiography dated 23.03.2020 (Figure 1b). 
In the IV contrast-free axial CT section dated 24.03.2020, ground-glass opacities 
(GGOs) were observed in the upper lobes, and an endobronchial intubation tube 
was present in the trachea (Figure 1c).
On 25.03.2020 and 29.03 2020, patient’s endotracheal aspirate (ETA)-COVID-19 
test resulted in positive. There was no overseas contact history. However, there was, 
a history of contact with the positive case (daughter), who was living in Istanbul 
and detected her positivity in RTEU hospital. Unfortunately, patient died on 
30.03.2020.
While being followed up in the cardiology service and coronary intensive care 
unit, the staff working in these units was thought to have been transmitted.
3.1.2 The Index patient 1 and the expanse GGOs on CT
Radiologically, there was no apparent opacity on the PA chest X-ray dated 
16.03.2020 (Figure 1a). Newly developed opacities in the right lung were noticeable 
on the control radiograph dated 23.03.2020 (Figure 1b). In the IV contrast-free 
axial CT section dated 24.03.2020, GGOs were observed in the upper lobes, and an 
endobronchial intubation tube was present in the trachea (Figure 1c).
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3.1.3 The Index patient 2
69 years-old, male. On 16.03.2020, he was hospitalized to the Pulmonology clinic 
with the diagnoses of hyperlipidemia, essential (primary) hypertension (HT), athero-
sclerotic heart disease, pacemaker use, and myalgia. There were 20 packs per month 
of smoking history for 25 years. The patient, whose preliminary diagnosis of viral 
pneumonia was interned, had a history of cough and sputum for 2 months, and had a 
fever since the last 3 days, lymphopenia, higher levels of CRP and D-dimer. SO2 levels 
were around 80 receiving with 6 lt/min O2 support and his tachypnea continued.
With prediagnosis of COVID-19, the nasopharyngeal (NF)-COVID-19 test 
performed on the same day was negative and this negativity continued the second 
NF-COVID-19 test carried on 20.03.2020. Patients’ endotracheal aspirate (ETA)-
COVID-19 test examined on 24.03.2020 was also negative.
Radiological findings of the patient were the following; Peripheral ground-
glass areas were detected in the axial Pulmonary CT Angiography section dated 
Figure 1. 
(a–c) Radiologically, there was no apparent opacity on the PA chest X-ray dated 16.03.2020 (a). Newly 
developed opacities in the right lung were noticeable on the control radiograph dated 23.03.2020 (b). In the IV 
contrast-free axial CT section dated 24.03.2020, GGOs were observed in the upper lobes, and an endobronchial 
intubation tube was present in the trachea (c).
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19.03.2020 (Figure 2a). Reticulonodular opacities were present on the PA chest 
x-ray of the same date (Figure 2b). Newly developed opacities were detected in 
both lung upper lobes on the control graph taken on 4.04.2020 (Figure 2c).
On 25.03.2020, the patient’s ETA COVID-19 test was found as positive and 
the case was recorded as the second COVID-19 case of Rize province. The patient 
diagnosed by COVID-19 via clinical and radiological imaging findings and was 
given hydroxychloroquine 2x400 mg loading and 2x200 mg/day maintenance doses 
(po), azithromycin 1x500 mg/day (po), oseltamivir 2x30 mg/day (po), piperacillin 
tazobactam 4x3.375 g (1.5 flacons) iv route. He, unfortunately, died on 10.04.2020.
While the patient was followed up by clinics of pulmonology and infectious 
diseases, it was thought that the personnel working in these units caught infection.
3.1.4 The Index patient 2 and the expanse peripheral GGOs on CT
Radiological findings of the patient was the following; Peripheral GGOs 
were detected in the axial Pulmonary CT Angiography section dated 19.03.2020 
(Figure 2a). Reticulonodular opacities were present on the PA chest x-ray of the 
same date (Figure 2b). Newly developed opacities were detected in both lung 
upper lobes on the control graph taken on 4.04.2020. Electrodes and pacemaker 
were displayed in the left pectoral region (Figure 2c).
3.2 Demographic and clinical features of health personnel
COVID-19 positive health workers among them were 27 and 63% (n = 17) 
of them were women and 37% (n = 10) were men and the mean age was 
33.2 ± 6.9 years. Of 55.6% (n = 15) cases were from Coronary ICU, 25.9% (n = 7) 
of them from Cardiology, and 18.5% (n = 5) of them from Infectious diseases 
clinic’s personnel. Occupational distributions of cases were follows; 51.9% 
(n = 14) were nurses, 29.6% (n = 8) were doctors, 11.1% (n = 3) were cleaning 
staff and 7.4% (n = 2) were secretaries. Male doctors were found to be signifi-
cantly higher than female doctors (70% vs. 5.9%, p < .001, Fisher’s exact test, see 
(Table 1).
Clinically, patients with symptoms including at least one symptom were 74.1% 
(n = 20). None of the HCWs had comorbidity. While 63% of the cases (n = 17) had 
a mild clinical level, 29.6% (n = 8) were of moderate and 7.4% (n = 2) were severe. 
None of them had severe clinical outcome and acute respiratory distress syndrome 
Figure 2. 
(a-c) Radiological findings of the patient was the following; peripheral GGOs were detected in the axial 
pulmonary CT angiography section dated 19.03.2020 (a). Reticulonodular opacities were present on the PA chest 
x-ray of the same date (b). Newly developed opacities were detected in both lung upper lobes on the control 
graph taken on 4.04.2020. Electrodes and pacemaker were displayed in the left pectoral region (c).
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Total Females Males Statistics
n = 27 n = 17 n = 10 t, z, or χ2 p value







Occupations, n (%) 15.901* .000
Nurse 14 
(51.9)
13 (76.5) 1 (10.0)
Doctor 8 (29.6) 1 (5.9) 7 (70.0)
Cleaning stuff 3 (11.1) 1 (5.9) 2 (20.0)
Sekretary 2 (7.4) 2 (11.8) 0
Working service, n (%) 1.318* .647
Coronary 15 
(55.6)
8 (47.1) 7 (70.0)
Cardiology 7 (25.9) 5 (29.4) 2 (20.0)
Infectious diseases 5 (18.5) 4 (23.5) 1 (10.0)
First PCR positivity (day)b 2 (0–7) 3 (0–7) 0 (0–4) −1.594 .111
1st PCR negativity (day)b 7 
(0–12)
8 (0–12) 6 
(5–10)
−1.384 .167











13 (76.5) 7 (70.0) .137* 1.00
COVID-contact, n (%) 2.830* .124
Knew 11 
(40.7)
9 (52.9) 2 (20.0)
Not-knew 16 
(59.3)
8 (47.1) 8 (80.0)
Hospitalization (day)b 0 
(0–15)
0 (0–14) 0 
(0–15)
−.116 .908
Clinic severity, n (%) 1.478* .578
Good 17 
(63.0)
12 (70.6) 5 (50.0)
Moderate 8 (29.6) 4 (23.5) 4 
(40.0)
Severe 2 (7.4) 1 (5.9) 1 (10.0)
Symptoms duration (day)b 5 (0–17) 4 (0–13) 7 (0–17) −1.295 .195
Symptoms presence, n (%)
Fever 15 
(55.6)
9 (52.9) 6 (60.0) .127* 1.00
Cough 11 
(40.7)
5 (29.4) 6 (60.0) 2.440* .224
Sore throat 9 (33.3) 5 (29.4) 4 
(40.0)
.318* .683
Shortness of breath 4 (14.8) 2 (11.8) 2 (20.0) .338* .613
Miyalgia 9 (33.3) 6 (35.3) 3 (30.0) .079* 1.00
Malaise 12 
(44.4)
19 (58.8) 2 (20.0) 3.844* .107
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(ARDS) requiring intensive care follow-up. While 40.7% (n = 11) of the cases knew 
COVID-contact, 59.3% (n = 16) did not. The hospitalization value (days) of the 
patients was in the range 0–15.
The findings were classified as severe (1–14 days), moderate (1–7 days), and 
mild (no hospitalization days) considering the duration of symptoms, length of 
hospital stay, and treatment practices. Milddefines, very close to asymptomatic 
patients who received only hydroxychloroquine therapy whereas moderate defines, 
symptomatic findings were evident, those who received hydroxychloroquine and 
azithromycin therapy followed in hospital and severe means, respiratory symptoms 
were severe, supportive therapy- receiving oxygen, hydroxychloroquine- azithro-
mycin and favipiravir therapy.
While the CT findings of the HCW were normal in 74.1% (n = 20), the appear-
ance of ground glass was found in 25.9% (n = 7), reversed halo or atoll sign was 
found in 7.4% (n = 2), consolidation was present in 3.7% of the cases (n = 1). 
Bilaterally involvement was detected in 7.4% of the cases (n = 2), peripheral and 
dorsal involvement in 25.9% of the cases (n = 7). The involvement of the middle 
and sub-zones was detected in 18.5% (n = 5) of the cases. Especially in the female 
gender, 76.5% (n = 13) of them had normal CT findings (see Table 1).
3.3 Comparison of laboratory measurements
The laboratory measurements of the patients in the first week of admission 
were compared with the test results when the patients were discharged from the 
hospital or re-admitted for control (second week). Laboratory measurements 
of HCWs were carried out at the first when they had symptoms and the second 
when they healed, and results were compared. A significant reduction was found 
Total Females Males Statistics
n = 27 n = 17 n = 10 t, z, or χ2 p value
Headache 10 
(37.0)
9 (52.9) 1 (10.0) 4.979* .042
Diarrhea 6 (22.2) 5 (29.4) 1 (10.0) 1.373* .363
Vomiting 4 (14.8) 4 (23.5) 0 2.762* .264
Loss of smell 5 (18.5) 3 (17.6) 2 (20.0) .023* 1.00
Loss of taste 6 (22.2) 4 (23.5) 2 (20.0) .045* 1.00
Smoking (Yes), n (%) 5 (18.5) 0 5 (50.0) 10.432* .003
CT findings (Yes), n (%) 7 (25.9) 4 (23.5) 3 (30.0) .137* 1.00
Reversed halo (Yes), n (%) 2 (7.4) 1 (5.9) 1 (10.0) .156* 1.00
Frosted-glass opacity (Yes), n (%) 7 (25.9) 4 (23.5) 3 (30.0) .137* 1.00
Consolidation (Yes), n (%) 1 (3.7) 0 1 (10.0) 1.765* .370
Bilaterally involvement (Yes), n (%) 2 (7.4) 0 2 (20.0) 3.672* .128
Peripheral and dorsal (Yes), n (%) 7 (25.9) 4 (23.5) 3 (30.0) .137* 1.00






Descriptives of health personnel infected with COVID-19 in terms of gender.
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between the mean PLT (238.3 vs. 204.3103/μL; z = −2.858, p = .004), MPV (10.0 
vs. 9.5 fL; z = −2.161, p = .031), CRP (2.9 vs. 1 g/dL; z = −2.490, p = .013), Hgb 
(13.5 vs. 13.1 g/dL; z = −2.300, p = .021), LDH (91.1 vs. 47.2 U/L; z = −4.542, 
p < .001), CK (77 vs. 60 U/L; z = −3.340, p = .001), CK-MB (0.8 vs. 0.5 mg/mL; 
z = −2.212, p = .027), troponin (all second examinations were < 3.2, z = −2.032, 
p = .042), ferritin (151.7 vs. 95 ng/mL; z = −2.822, p = .005) levels whereas a 
significant increase was found the mean albumin (43.8 vs. 44.4 g/L; z = −2.000, 
p = .046), K+ (4.1 vs. 4.3 mmol/L; t(26) = −2.213, p = .036) and Na+ (137.5 vs. 
138.2 mmol/L; t(26) = −2.174, p = .039) levels. The D-dimer had increased in 2 
poor-clinical findings of HCWs, but their mean values were within normal limits 
(see Table 2).
Laboratory measurementsa Statistics
First Second paired-t or z p value
WBC (103/μL)(N: 4–10) 6.3 (1.3) 6.3 (1.5) −.102 .919
NE (%) (N: 50–70) 61.5 (9.7) 58.4 (8.8) −1.765 .078
LY (%) (N: 20–40) 31.4 (9.8) 28.9 (8.5) −1.105 .269
N/L ratio 2.3 (1.6) 2.2 (0.8) −.288 .773
PLT (103/μL)(N: 100–400) 238.3 (43.0) 204.3 (46.5) −2.858 .004
MPV (fL) (N: 6.5–12) 10.0 (1.1) 9.5 (0.8) −2.161 .031
PDW (fL) (N: 15–17) 16.0 (0.3) 16.1 (0.3) −.345 .730
Hb (g/dL) (N: 10–16) 13.5 (1.1) 13.1 (1.2) −2.300 .021
APTT (sec) (N: 26–38) 29.1 (2.4) 28.7 (1.9) −.170 .865
PT (sec) (N: 12–16.5) 13.7 (2.5) 13.1 (0.7) −.787 .432
CRP (mg/L)b (N: 0–5) 2.9 (0.4–114) 1 (0.3–16.7) −2.490 .013
AST (U/L) (N: 0–35) 21.4 (5.7) 20.4 (6.7) −.994 .320
ALT (U/L) (N: 0–35) 19.8 (0.9) 23.6 (11.7) −1.828 .068
LDH (U/L) (N: 0–248) 191.1 (56.1) 47.2 (4.0) −4.542 .000
Albumin (g/L) (N: 35–52) 43.8 (3.3) 44.4 (2.9) −2.000 .046
K (mmol/L)a (N: 3.5–5.1) 4.1 (0.4) 4.3 (0.4) −2.213 .036
Na (mmol/L)a (N: 136–146) 137.5 (2.4) 138.2 (1.9) −2.174 .039
Cre (mg/dL) (N: 0.51–0.95) 0.6 (0.1) 0.6 (0.1) −.294 .769
CK (U/L)b (N: 0–145) 77 (55–684) 60 (35–136) −3.340 .001
CK-MB (mg/mL) (N: 0–3.1) 0.8 (0.6) 0.5 (0.1) −2.212 .027
Troponin (pg/mL)b (N: 0–15.6) <3.2 (<3.2–7.9) <3.2 −2.032 .042
D-dimer (μgFEU/mL)(N: 0–0.5) <.25 (<.25–0.3) <.25 −1.890 .059
Sedim (mm/hour) (N: 0–20) 19.2 (17.9) 13.1 (7.7) −1.298 .194
Ferritin (ng/mL) (N: 21.8–274.6) 151.7 (115.7) 95.0 (38.8) −2.822 .005
aMean (standard deviation)
bMedian (minimum-maksimum)
N: normal reference range; WBC: White blood cell; NE: neutrophil; LY: lymphocyte; N/L: neutrophil/lymphocyte; 
PLT: platelet.
Table 2. 
Comparison of the first and second values of laboratory measurements.
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3.4 Imaging findings
3.4.1 The HCW with the worst clinical findings and the expanse GGOs on CT
44 year old male patient, it was noteworthy that in the first examination 
(Figure 3a), the GGOs observed in the lower lobe of the left lung expanded in 
the control examination on iv non-contrasted axial CT images obtained with an 
interval of 4 days (Figure 3b). In the control evaluation in the ground glass area 
(Figure 3c) located in the left lobe lower lobe posterobasal segment, fibrous bands 
developed (Figure 3d).
3.4.2 The HCW with good clinical findings and the halo sign on CT
41 year old female patient, in the CT images of 31.03.2020 (Figure 4a) and 
5.05.2020 (Figure 4b), the minimum-intensity-projection coronal cross-sectional 
CT images show different areas of involvement. Right lung lower lobe findings 
(Figure 4a) declined in control, but consolidation developed with a reverse halo 
sign in posterobasal (Figure 4b).
3.4.3  The HCW with asymptomatic clinical findings and the minimal peripheral 
GGOs on CT
34-year-old female patient, peripheral small-sized GGOs are observed in the 
iv non-contrasted axial CT images obtained every 10 days apart (Figure 5a). The 
GGOswere diminished but new ground glass areas developed (Figure 5b).
4. Discussion
In many countries, especially China, which is the country where the COVID-
19 epidemic was first seen, the healthcare professionals became the “frontline” 
occupational group struggling against COVID-19 [13–15]. According to the first 
date of February 11, 2020, 1716 Chinese HCWs have been reported to have COVID-
19 infection when the first 15 affected cases were reported in Wuhan [13]. On 
February 17, 2020, the CDC weekly report reported that a total of 3,019 Chinese 
HCWs were infected with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) and 1,716 of them were confirmed with COVID-19. As of February 20, ten 
health workers died [16]. Reasons why healthcare professionals get an increasing 
number of infections were the following; 1) People who are unaware of the disease 
and epidemic are transmitted to HCWs who do not have protective clothing when 
they return to their place of residence, 2) Inadequate protective equipment supply 
especially for primary HCWs in primary care, and 3) Computed tomography (CT) 
scan results before COVID-19 case definition criteria are not specified and then it 
was later seen as sudden changes in the criteria [13, 14].
After the first case reported in Turkey and the Ministry of Health have pub-
lished the management and treatment algorithm guides. The possible case and the 
definite case definitions were made by them and HCWs were informed. The use of 
protective equipment was recommended by the Governments [17, 18]. In the Rize 
province, which was 1150 km away since the first cases originated from Istanbul, 16 
(59.3%) of the HCWs did not have awareness about index cases. The use of surgical 
masks was widespread among the staff, but the mask use of the patient and accom-
panying people to patients weremissing, and the highly protective respiratory mask 
Fighting the COVID-19 Pandemic
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was used in case of intubation. While 63% of the cases (n = 17) had a mild clinical 
level, 29.6% (n = 8) were moderate and 7.4% (n = 2) were severe. Index 2 case had 
comorbidities and died but there was no severe clinical condition such as ARDS or 
death among the medical staff which were in contact with her.
In our study, the mean age of the total 27 HCW was 33.2 ± 6.9 years. The median 
age was 39 (IQR: 32–48.5 years) in studies conducted in health workers in China 
[19] the age ranges of 72 HCWs, 33 of whom were at high-risk Section 39 and gen-
eral departments were 21–66 years [13]. It was similar to the report showing the age 
of 41 (IQR: 32–52 years) from Zhejiang province in the first studies [20]. The aver-
age age in the local study of Wuhan, the starting place of the outbreak, was 56 (IQR: 
42–68 years) [21]. In another study conducted in Wuhan, the average age was 49.0 
(IQR 41.0–58.0) [22]. In our study, 63% (n = 17) of the 27 health personnel were 
Figure 3. 
(a-d) 44 year old male patient, it was noteworthy that in the first examination (a), the GGOs observed in the 
lower lobe of the left lung expanded in the control examination on iv non-contrasted axial CT images obtained 
with an interval of 4 days (b). In the control evaluation in the ground glass area (c) located in the left lobe 
lower lobe posterobasal segment, fibrous bands developed (d).
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female and 37% (n = 10) were male and Wang et al. reported that female patients 
constituted the majority of all cases (61.25%), the male ratio was (38.75%) [19]. 
Ran et al. showed that the genders were similar (χ2 = 2.243, p = 0.134) [13]. In other 
studies conducted in Wuhan, most of the infected patients were men 30/41 (73%), 
and (54.3%) were male [15, 21], respectively. Most of our HCW cases were high-
risk departments workers, such as coronary intensive care. It was found similar to 
the study conducted in Wuhan [13]. In our study, 51.9% (n = 14) of the infected 
profession group were female nurses and 13 (76.5%) were among the nurses. It was 
similar to the work of Wang et al. [19] the ratio as 41/80 (51.25%). In the com-
parison between doctors in our study, male doctors were found to be significantly 
Figure 4. 
(a-d) 41 year old female patient, in the CT images of 31.03.2020 (a) and 5.05.2020 (b), the minimum-intensity-
projection coronal cross-sectional CT images show different areas of involvement. Right lung lower lobe findings 
(a) declined in control, but consolidation developed with a reverse halo sign in posterobasal (b).
Figure 5. 
(a, b) 34-year-old female patient, peripheral small-sized GGOs are observed in the iv non-contrasted 
axial CT images obtained every 10 days apart (a). The GGOswere diminished but new ground glass areas 
developed (b).
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higher than female doctors (70% vs. 5.9%, p < .001). It was observed that thorax CT 
findings were normal in the female gender.
In our study, none of the healthcare professionals had comorbidity. The clinic of 
63% (n = 17) of the cases was followed up with outpatient home isolation. Wang D 
et al., also constituted a significant number of HCWs in the majority of non-inten-
sive care patients (p < .001) [21]. However, having a non-intensive care follow-up 
suggested that they were clinically mild. In previous studies, it was shown that 
this infection may cause severe clinical picture in non-comorbid patients, however 
hypertension, diabetes, cardiovascular, chronic obstructive pulmonary diseases, 
liver, and kidney failure are risk-causing comorbidities [15, 19–21].
The most common clinical symptoms in our study were present in 55.6% 
(n = 15) of fever and 40.7% (n = 11) of cough, respectively, less than the signs of 
fever and cough in previous studies [15, 19–21]. Chinese cases showed more severe 
clinical. Fever was seen at a relatively low rate in the European studies which were 
more extensive studies and they included mild to moderate COVID-19 (45.7% and 
48%) [23, 24]. The cough was reported at high rates in European studies (63.2 and 
80%) [22, 23]. Shortness of breath was present in 14.8% of the cases (n = 4), which 
was less than the previous study results [15, 21–23]. In our study, the complaint of 
malaise was present in 44.4% of the cases (n = 12) and myalgia in 33.3% (n = 9), 
this rate was higher than that of the health workers in Wuhan-China [19] compared 
to other studies [15, 20–23] was less. The low levels of these findings may be since 
most of the clinical conditions are good-moderate or the number of cases was lim-
ited. According to clinical studies in Asia [15, 19–21], the most common symptoms 
were fever, cough, shortness of breath, muscle pain, arthralgia, headache, diarrhea. 
With the spread of COVID-19 in Europe, he emphasized a new atypical presenta-
tion of the disease: smell and taste dysfunction [22–27].
In our study, anosmia was detected in 18.5% of the cases (n = 5) and complaints 
about the sense of taste in 22.2% of the cases (n = 6). Taste and smell tests were not 
performed, only the presence of symptoms was said by the staff themselves, similar 
to the previous studies [24]. The rate of anosmia in Europe was shown to be in 201 
patients (14.2%) [22]. Even in a more comprehensive study of 2428 patient series, 
74% of the 80 subjects tested were positive despite limited access. Cases; only 51% 
reported their symptoms as cough or fever, while 16% reported it as isolated anos-
mia as an isolated symptom [25]. Another recent study reported that anosmia was 
recorded in 73% of patients and the first symptom in 26.6% before the diagnosis of 
COVID-19 [26]. In the European study (54.2%) there was a taste impairment [22]. 
In a study of 417 mild to moderate COVID-19 patients in European hospitals, 85.6% 
and 88.0% of the patients reported smell and taste impairment and a significant 
relationship between both disorders (p < 0.001) [23]. It has been argued that the 
reason for sensory loss may be due to neurotropic and neuroinvasive coronaviruses 
[27]. In our study, headache complaints were found in 37% of the cases (n = 10), 
and headache rates in female HCWs infected with COVID-19 were found to be sig-
nificantly higher than men (52.9% vs. 10%, p = .042, Fisher’s exact test). All other 
complaints except for headaches were found in male and female workers at similar 
rates (p > .05 for all).
While it was 21/62 (34%) (2021) close to our study in Zhejiang provincial, it 
was lower in studies from Wuhan; The most comprehensive study on 138 patients 
Wang D et all. Headache was 6.5% in 9 people in total (15, 19–21). But in the more 
extensive European mild to moderate Coronavirus Disease 2019 study, this rate was 
much higher. The most common symptom was reported asheadache (70.3%) [22]. 
Diarrhea, another symptom in our study, was in 22.2% (n = 6) of the cases. In two 
studies [19, 21] involving health workers in China (80 and 138 cases), it was 18.75% 
and 10.1%, respectively, in other studies, the rate was reported to be much (3–8%) 
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less [15, 20]. In European studies, it was 473/1420 (38.1%) [22] and 50% [23]. In our 
study, vomiting was reported in 14.8% of the cases (n = 4), less in Chinese studies 
[21, 22], and in European studies at a similar rate [22, 23].
As laboratory parameters; WBC, neutrophil, and lymphocyte levels were 
normal. However, the decrease in PLT, MPV, hemoglobin levels in the first and last 
measurements in hospital admission was found significant.
From the place where the outbreak and clinical findings were severe, for 
instance, Huang C. et al. reported 25% leukopenia and 63% lymphopenia [15]. In 
the Chinese HCWs study, 19 of 80 patients (23.75%) had leukopenia and 38 (47.5%) 
had lymphopenia [19]. In the Zhejiang province study, there was leukopenia and 
42% lymphopenia at 31% at the time of admission [20]. Wang et al. showed that 
although the total of 138 patients was within normal limits, white blood cell and 
neutrophil counts were significantly higher in intensive care patients [21]. In our 
study, neutrophil/lymphocyte rate (NLR) was normal, as the clinical well-being 
ratio of HCWs was high. In the study in which they compared mild type and 
severe-critical patient groups in China, NLR was the most useful prognostic factor 
affecting prognosis in patients with a severe disease with COVID-19 pneumonia. 
In the severe group, the blood neutrophil count was higher than in the mild group, 
the blood lymphocyte count was significantly lower, and the bacterial infection 
rate increased significantly [28]. When the results of many studies in China were 
evaluated, high NLR was argued to be an independent prognostic biomarker for 
COVID-19 patients [29, 30]. Studies were reporting that MPV was elevated during 
the active period of some viral infection [31, 32]. In our study, it was noteworthy 
that the HCW was higher than the values  of the first measurement MPV levels were 
higher than that of recovery period measurement (10.0 vs. 9.5; z = −2.161, p = .031).
In our study, mild elevation was found in two patients with moderate to severe 
pneumonia signs, and total D-dimer measurements were in the normal range and 
were similar to some Chinese studies [19, 20], but were high in intensive care patients 
in China [15, 21, 33]. Tang N et al. [34] showed that abnormal coagulation results, 
especially markedly elevated D-dimer and fibrin degradation product FDP, are com-
mon in deaths with new coronavirus pneumonia NCP (34).PLT levels were within 
normal limits in all studies, including intensive care patients [15, 19–21, 33]. Lippi G 
and Plebani M [33], reported that the country where the epidemic spread, increased 
C-reactive protein (CRP) and lactate dehydrogenase (LDH) in their letters, which 
summarize abnormal laboratory parameters, which are prognostic biomarkers 
in studies in most Wuhan studies in China, were shown as negative prognoses. In 
our study, a significant difference was found between the median value of the first 
and second CRP (g/dL) levels (2.9 vs. 1). Another significant difference was found 
between the mean first and second LDH (U/L) levels (91.1 vs. 47.2). A significant 
difference was found between the mean values  of first and second albumin (g/L) 
levels in our cases (43.8 vs. 44.4). The value of troponin levels in the second measure-
ment was found to be <3.2 in all cases. Although our cases showed clinically good to 
moderate clinics [34], they were consistent with the study. We found a significant 
difference between the first and second median CK (U/L) levels (77 vs. 60). A 
significant difference was found between the first CK-MB (mg/mL) of the cases and 
the second CK-MB (0.8 vs. 0.5). There was a significant difference between the mean 
values of the first ferritin (ng/mL) and the second ferritin (151.7 vs. 95).
Computed Tomography (CT) can help in diagnosis and differential diagnosis in 
patients with COVID-19 [35] and is particularly high when evaluated with serial CT 
images. RT-PCR provides a chance to catch 93% of negative patients earlier [36] his-
tory of contact, clinical findings, and imaging findings were considered more sensitive 
in the diagnosis of COVID-19 [36]. Typical radiological findings of COVID-19 pneu-
monia have been reported as interstitial inflammation, ground-glass opacities, crazy 
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paving appearance, and bilateral or multiple lobular or subsegmental widespread 
consolidation [19–21, 35–37]. In our study, pneumonia findings and CT findings were 
seen in 7 persons (25.9%) and in 20 subjects (74.1%), there was no CT involvement. 
The clinical progresses was good in HCWs at the beginning of the outbreak.
While not being aware of the cases initially caused contamination by contact, it 
may be related to the aerosol contact formed later by intubation. Nevertheless, the 
timely implementation of protective measures prevented negative consequences. 
The clinical reflection severity of the contamination was low, the radiological reflec-
tion was moderate, and the laboratory reflections were partly significant in HCWs. 
Acute respiratory distress syndrome (ARDS) was not seen in any healthcare worker.
In conclusion, HCWs are a respected professional group that must be at the 
forefront of the epidemic and the center of the risk. The risk decreases when the 
virus load is reduced using PPE. It would be also crucial to ensure that complete 
PPE, including the electrical air purification device, is fitted, providing a negative 
pressure isolation ward environment that prevents patients from spreading to the 
rest of the infectious pathogen.
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